SmithKline buys German OTC/vitamin firm; selling Sine-Off, Teldrin, OraFix.
This article was originally published in The Tan Sheet
Executive Summary
SMITHKLINE BUYING GERMAN OTC/VITAMIN COMPANY ABTEI PHARMA-VERTRIEBS GMBH for $142 mil., the firm announced Dec. 21. Bielefeld, Westphalia-based Abtei is said to be the leading mass marketer of OTCs in Germany, with 1994 sales of $77 mil. The deal is expected to close Feb. 1, subject to approval by the Federal Cartel Office in Germany.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning